Remittance Advice Alerts/PROMISe Banner Pages
Subject: Revisions for Participating Drug Company list for Medicaid Drug Rebate Program
Banner Date: March 30, 2018
Cycles: 40, 41, 42
Provider types: 07, 08, 09, 24, 31
 
Subject: Revisions for Participating Drug Company list for Medicaid Drug Rebate Program
 
For a drug product to be compensable through the Medical Assistance (MA) Program, the company (labeler) that markets the product must participate in the Federal Medicaid Drug Rebate Program.
 
The revisions to the list below, unless otherwise indicated, are effective April 1, 2018. Terminations and additions apply only to those National Drug Codes (NDCs) beginning with the five-digit labeler code indicated, and not to other NDCs that may be marketed by that company under a different labeler code.
 
NEW and REINSTATED LABELERS
AMNEAL PHARMACEUTICALS (60219)
ACI HEALTHCARE USA, INC. (71093)
KTE PHARMA, INCORPORATED (71287)*
AKRON PHARMA INC. (71399)
ADAMAS PHARMA LLC (70482)
ULTRAGENYX PHARMACEUTICAL, INC. (69794)
VITRUVIAS THERAPEUTICS, INC. (69680)
SPARK THERAPEUTICS, INC. (71394)
OPTINOSE US, INC. (71143)
CUSTOPHARMA, INC. dba LEUCADIA PHARMACEUTICALS (24201)
CROWN LABORATORIES, INC. (00316)
PIRAMAL CRITICAL CARE (66794)
 
*effective January 1, 2018
 
TERMINATED LABELERS, MANDATORY AND VOLUNTARY
ZARS PHARMA, INC. (43469)
ACELLA PHARMACEUTICALS (42192)
ROMARK LABORATORIES (67546)
METCON LABS (49808)


 

 

Back to RA Banner List